| Not Yet Recruiting | De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Che NCT06446557 | University Hospital, Rouen | Phase 3 |
| Recruiting | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell NCT07321106 | Cartography Biosciences | Phase 1 |
| Not Yet Recruiting | xDRIVE in Metastatic Colorectal Cancer NCT06929338 | First Ascent Biomedical Inc. | — |
| Recruiting | Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAG NCT06202183 | Dana-Farber Cancer Institute | N/A |
| Unknown | PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer NCT06335147 | Henan Cancer Hospital | N/A |
| Completed | CALM: Managing Distress in Malignant Brain Cancer NCT06180460 | Virginia Commonwealth University | N/A |
| Terminated | A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Can NCT05983367 | Inspirna, Inc. | Phase 2 |
| Recruiting | A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors NCT05848739 | Sapience Therapeutics | Phase 1 |
| Completed | REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients NCT05396807 | University of Rome Tor Vergata | N/A |
| Recruiting | Liver Embolization Approaches for Tumor Management NCT05714124 | IRCCS San Raffaele | — |
| Withdrawn | Hepatic Artery Infusion (HAI) Program at Duke University NCT04511793 | Michael Lidsky, M.D. | N/A |
| Unknown | SGM-101 in Colorectal Lung Metastases NCT04737213 | Leiden University Medical Center | Phase 2 |
| Completed | A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer NCT04322539 | Hutchison Medipharma Limited | Phase 3 |
| Recruiting | Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer NCT03803553 | Massachusetts General Hospital | Phase 3 |
| Unknown | The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer NCT04416854 | Fudan University | Phase 3 |
| Completed | Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsu NCT05468892 | University of Campania Luigi Vanvitelli | Phase 2 |
| Withdrawn | Imaging with [89Zr]Panitumumab-PET/MRI in Patients with Newly Diagnosed Colorectal Cancer NCT03764137 | University of Alabama at Birmingham | Phase 1 / Phase 2 |
| Active Not Recruiting | Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients NCT03694938 | Poitiers University Hospital | N/A |
| Terminated | Curcumin in Combination With 5FU for Colon Cancer NCT02724202 | Baylor Research Institute | EARLY_Phase 1 |
| Completed | A Study of ASN007 in Patients With Advanced Solid Tumors NCT03415126 | Asana BioSciences | Phase 1 |
| Completed | Pembrolizumab + Poly-ICLC in MRP Colon Cancer NCT02834052 | Asha Nayak | Phase 1 / Phase 2 |
| Completed | A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers NCT03251378 | Hutchison Medipharma Limited | Phase 1 |
| Completed | ZETA : Prospective Observational Study NCT03730558 | Recherche clinique | — |
| Terminated | Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers NCT03073473 | Cota Inc. | — |
| Completed | Development of Clinical and Biological Database in Colorectal Cancer NCT04186117 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Completed | Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients NCT02655952 | WntResearch AB | Phase 1 |
| Unknown | Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer NCT02618356 | Fudan University | Phase 2 |
| Completed | Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors NCT03176485 | University of Arizona | N/A |
| Unknown | A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients NCT02291744 | Fudan University | Phase 2 |
| Unknown | Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer NCT02254941 | Grupo Espanol Multidisciplinario del Cancer Digestivo | — |
| Withdrawn | Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors NCT01936961 | Western Regional Medical Center | N/A |
| Completed | Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response NCT01292356 | Poitiers University Hospital | Phase 2 |
| Unknown | A Study to Assess PV-10 Chemoablation of Cancer of the Liver NCT00986661 | Provectus Biopharmaceuticals, Inc. | Phase 1 |